Da klinisk erfaring ikke giver evidens for immunoglobuliners karcinogene potentiale, er der ikke udført eksperimentelle undersøgelse hos heterogene arter.
Since clinical experience provides no evidence for carcinogenic potential of immunoglobulins, no experimental studies in heterogeneous species were performed.